A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population

被引:440
作者
Morikawa, T
Kato, J
Yamaji, Y
Wada, R
Mitsushima, T
Shiratori, Y
机构
[1] Okayama Univ, Grad Sch Med & Dent, Dept Med & Med Sci, Okayama 7008558, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] Kameda Gen Hosp, Dept Gastroenterol, Chiba, Japan
关键词
D O I
10.1053/j.gastro.2005.05.056
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The fecal occult blood test (FOBT) is recommended as a screening test for colorectal cancer, but there are few reliable studies on the accuracy of immunochemical FOBT. The aim of this study was to analyze the sensitivity of immunochemical FOBT and to compare the results with the findings from complete colonoscopy. Method : Asymptomatic adults underwent 1-time immunochemical FOBT and total colonoscopy simultaneously. The prevalence and location of colorectal neoplasia were determined by colonoscopy. The results of immunochemical FOBT and the colonoscopic findings were compared. Results: Of 21,805 patients, immunochemical FOBT was positive in 1231 cases (5.6%). The sensitivity of 1-time immunochemical FOBT for detecting advanced neoplasia and invasive cancer was 27.1% and 65.8%, respectively. In addition, the sensitivity for invasive cancer according to Dukes' stage showed 50.0% for Dukes' stage A, 70.0% for Dukes' stage B, and 78.3% for Dukes' stages C or D. The sensitivity for detecting advanced neoplasia at the proximal colon was significantly lower than that detected in the distal colon (16.3% vs 30.7%, P = .00007). Conclusions: Although the screening of asymptomatic patients with immunochemical FOBT can identify patients with colorectal neoplasia to a certain extent, the sensitivity is relatively low and different according to the tumor location. Therefore, programmatic and repeated screening by immunochemical FOBT may be necessary to increase sensitivity for colorectal cancer detection.
引用
收藏
页码:422 / 428
页数:7
相关论文
共 40 条
[1]  
AHLQUIST DA, 1993, JAMA-J AM MED ASSOC, V269, P1261
[2]   HEMOCCULT SCREENING IN DETECTING COLORECTAL NEOPLASM - SENSITIVITY, SPECIFICITY, AND PREDICTIVE VALUE - LONG-TERM FOLLOW-UP IN A LARGE GROUP-PRACTICE SETTING [J].
ALLISON, JE ;
FELDMAN, R ;
TEKAWA, IS .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (05) :328-333
[3]  
Allison JE, 2001, NEW ENGL J MED, V345, P1850
[4]   A comparison of fecal occult-blood tests for colorectal-cancer screening [J].
Allison, JE ;
Tekawa, IS ;
Ransom, LJ ;
Adrain, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :155-159
[5]   Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer [J].
Castiglione, G ;
Zappa, M ;
Grazzini, G ;
Mazzotta, A ;
Biagini, M ;
Salvadori, P ;
Ciatto, S .
BRITISH JOURNAL OF CANCER, 1996, 74 (01) :141-144
[6]   PREVALENCE OF POLYPS IN AN AUTOPSY SERIES FROM AREAS WITH VARYING INCIDENCE OF LARGE-BOWEL CANCER [J].
CLARK, JC ;
COLLAN, Y ;
EIDE, TJ ;
ESTEVE, J ;
EWEN, S ;
GIBBS, NM ;
JENSEN, OM ;
KOSKELA, E ;
MACLENNAN, R ;
SIMPSON, JG ;
STALSBERG, H ;
ZARIDZE, DG .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (02) :179-186
[7]   SENSITIVITY OF GUAIAC-IMPREGNATED CARDS FOR THE DETECTION OF COLORECTAL NEOPLASIA [J].
CROWLEY, ML ;
FREEMAN, LD ;
MOTTET, MD ;
STRONG, RM ;
SWEENEY, BF ;
BROWER, RA ;
SHARMA, SP ;
ANDERSON, DS .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1983, 5 (02) :127-130
[8]  
Greenberg PD, 2000, AM J GASTROENTEROL, V95, P1331
[9]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[10]   PROSPECTIVE-STUDY OF THE FREQUENCY AND SIZE DISTRIBUTION OF POLYPS MISSED BY COLONOSCOPY [J].
HIXSON, LJ ;
FENNERTY, MB ;
SAMPLINER, RE ;
MCGEE, D ;
GAREWAL, H .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (22) :1769-1772